Thyroid, Obesity and Metabolism
Autor: | Livio Luzi |
---|---|
EAN: | 9783030802677 |
eBook Format: | |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 27.08.2021 |
Untertitel: | Exploring Links Between Thyroid Function, Obesity, Metabolism and Lifestyle |
Kategorie: | |
Schlagworte: | Fat mass;Iodine deficiency;treatment;Classification;Diagnosis;hypothyroidism;cardiovascular system |
106,99 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
This book will provide readers with up-to-date information on thyroid diseases, obesity and metabolic syndrome. The innovative element is the presentation and exploration of possible connections linking thyroid diseases and metabolism dysfunction.
Starting from the classification and diagnosis of thyroid diseases, obesity and metabolic syndrome, techniques to study and treat each of the mentioned diseases are given in an easy-to-use way.
This volume will be a useful tool for endocrinologists, diabetologists, dieticians, and any professionals involved in the treatment of thyroid diseases.
Livio Luzi, M.D., is Professor of Endocrinology at the University of Milan and is the Director of the Department of Endocrinology, Nutrition and Metabolic Diseases at the IRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
After receiving his medical degrees from the University of Milan, Prof. Luzi completed his research fellowships in Endocrinology at Yale University and in Diabetes at the University of Texas Health Science Center. From 1993-1996 he was on the faculty of Brigham and Women's Hospital, Harvard Medical School as an Assistant Professor, before returning to Italy. Prof. Luzi was also Adjunct Professor of Surgery at the University of Miami.
The clinical activity of Prof. Livio Luzi takes place in the Endocrinology Department and under the Ambulatory activities at the IRCCS MultiMedica. The clinical scientific activities conducted by Endocrinology Department concern the pathophysiology, the research for innovative therapies and the evaluation of current diagnostic procedures for type 1 and type 2 diabetes, obesity and metabolic diseases. Furthermore, special attention is also paid to the study of cardiovascular, metabolic and bone complications in patients with these diseases.